The number of women undergoing breast cancer treatment in India is projected to rise by 50,000 annually throughout this decade, with the economic burden...
U.S. pharmaceutical company Eli Lilly plans to introduce its blockbuster drug ‘Tirzepatide‘ to India in 2025. The drug, renowned for treating type 2...